This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Praxair Inc
PX : NYSE : Basic Materials
$103.36 up1.30 | 1.30%
Today's Range: 102.21 - 103.60
Avg. Daily Volume: 1,856,100
02/12/16 - 1:40 PM ET

Financial Analysis

PRAXAIR INC's gross profit margin for the fourth quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased. PRAXAIR INC has weak liquidity. Currently, the Quick Ratio is 0.92 which shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 21.94% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q4 FY15 Q4 FY14
Net Sales ($mil)2595.02990.0
EBITDA ($mil)871.0950.0
EBIT ($mil)596.0659.0
Net Income ($mil)422.0302.0

Balance Sheet Q4 FY15 Q4 FY14
Cash & Equiv. ($mil)147.0126.0
Total Assets ($mil)18319.019802.0
Total Debt ($mil)9231.09258.0
Equity ($mil)4389.05623.0

Profitability Q4 FY15 Q4 FY14
Gross Profit Margin45.0543.51
EBITDA Margin33.5631.77
Operating Margin22.9722.04
Sales Turnover0.590.62
Return on Assets8.448.55
Return on Equity35.2430.12
Debt Q4 FY15 Q4 FY14
Current Ratio1.391.14
Interest Expense0.053.0
Interest Coverage0.012.43

Share Data Q4 FY15 Q4 FY14
Shares outstanding (mil)284.85289.26
Div / share0.720.65
Book value / share15.4119.44
Institutional Own % n/a n/a
Avg Daily Volume1807845.01915789.0


HOLD. PRAXAIR INC's P/E ratio indicates a discount compared to an average of 21.79 for the Chemicals industry and a value on par with the S&P 500 average of 21.13. Conducting a second comparison, its price-to-book ratio of 6.85 indicates a significant premium versus the S&P 500 average of 2.51 and a premium versus the industry average of 5.85. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
PX 19.69 Peers 21.79   PX 11.21 Peers 15.11

Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.

PX is trading at a valuation on par with its peers.


Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

PX is trading at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
PX 17.44 Peers 16.92   PX 7.03 Peers 3.20

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

PX is trading at a premium to its peers.


Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

PX trades at a significant premium to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
PX 6.85 Peers 5.85   PX -6.63 Peers -56.38

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

PX is trading at a premium to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

PX is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
PX 2.79 Peers 1.95   PX -12.20 Peers -7.76

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

PX is trading at a significant premium to its industry.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

PX significantly trails its peers on the basis of sales growth



Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs